Literature DB >> 15632029

Different mechanisms for changes in glucose uptake of the right and left ventricular myocardium in pulmonary hypertension.

Regine Kluge1, Henryk Barthel, Hans Pankau, Anita Seese, Joachim Schauer, Hubertus Wirtz, Hans-Juergen Seyfarth, Joerg Steinbach, Osama Sabri, Joerg Winkler.   

Abstract

UNLABELLED: In patients with pulmonary hypertension (PH) the right ventricular (RV)-to-left ventricular (LV) ratio of fatty acid uptake is reduced. In animal studies, such a finding was combined with an increased glucose uptake in RV myocardium. The aim of this study was to measure the metabolic rates of glucose uptake for the RV and LV myocardium in patients in relationship to parameters of RV and LV function.
METHODS: Thirty patients with PH underwent PET with (18)F-FDG and SPECT with (99m)Tc-tetrofosmine. The metabolic rate of glucose uptake was determined for RV and LV myocardium using the method of Patlak. A right heart catheter, thermodilution, and Doppler sonography were used to characterize RV and LV function. From these methods, the stroke work of both ventricles and the RV Tei index were calculated.
RESULTS: RV-to-LV ratios of (18)F-FDG-uptake increased with rising pulmonary arteriolar resistance (PAR). With increasing PAR, the metabolic rate of glucose uptake of the left ventricle decreased (r = -0.547; P < 0.01) together with LV stroke work (r = -0.838; P < 0.001). The metabolic rate of glucose uptake of the right ventricle, however, correlated neither with RV stroke work (r = 0.124) nor with PAR (r = 0.189) but with the Tei index (r = 0.78; P < 0.001).
CONCLUSION: Increasing right-to-left ratios of glucose uptake with an increasing pressure load in the right ventricle in PH are caused mainly by a significant reduction in the LV metabolic rate of glucose uptake. This is obviously due to a reduced energy demand of the LV myocardium caused by reduced stroke work. An increased metabolic rate of glucose uptake in the right ventricle presumably indicates RV impairment, correlating with the Tei index, which is an established prognostic parameter for cardiac dysfunction and poor survival.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15632029

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  19 in total

1.  Clinical significance of quantitative assessment of right ventricular glucose metabolism in patients with heart failure with reduced ejection fraction.

Authors:  Szu-Ying Tsai; Yen-Wen Wu; Shan-Ying Wang; Yu-Chien Shiau; Kuan-Ming Chiu; Hao-Yuan Tsai; Chien-Lin Lee; Jung-Cheng Hsu; Chung-Ming Tu; Heng-Hsu Lin; Shan-Hui Huang
Journal:  Eur J Nucl Med Mol Imaging       Date:  2019-08-13       Impact factor: 9.236

2.  Hypoxia-induced glucose-6-phosphate dehydrogenase overexpression and -activation in pulmonary artery smooth muscle cells: implication in pulmonary hypertension.

Authors:  Sukrutha Chettimada; Rakhee Gupte; Dhwajbahadur Rawat; Sarah A Gebb; Ivan F McMurtry; Sachin A Gupte
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2014-12-05       Impact factor: 5.464

Review 3.  Novel therapeutic approaches to preserve the right ventricle.

Authors:  Samar Farha; Erika L Lundgrin; Serpil C Erzurum
Journal:  Curr Heart Fail Rep       Date:  2013-03

Review 4.  Right heart imaging in patients with heart failure: a tale of two ventricles.

Authors:  Myriam Amsallem; Tatiana Kuznetsova; Kate Hanneman; Andre Denault; François Haddad
Journal:  Curr Opin Cardiol       Date:  2016-09       Impact factor: 2.161

Review 5.  Metabolic Dysfunction in Pulmonary Arterial Hypertension.

Authors:  Tufik R Assad; Anna R Hemnes
Journal:  Curr Hypertens Rep       Date:  2015-03       Impact factor: 5.369

6.  Evaluation of right ventricular volume and ejection fraction by gated (18)F-FDG PET in patients with pulmonary hypertension: comparison with cardiac MRI and CT.

Authors:  Lei Wang; Yan Zhang; Chaowu Yan; Jianguo He; Changming Xiong; Shihua Zhao; Wei Fang
Journal:  J Nucl Cardiol       Date:  2013-01-26       Impact factor: 5.952

7.  Effects of an endothelin receptor antagonist, Macitentan, on right ventricular substrate utilization and function in a Sugen 5416/hypoxia rat model of severe pulmonary arterial hypertension.

Authors:  Katarzyna Drozd; Ali Ahmadi; Yupu Deng; Baohua Jiang; Julia Petryk; Stephanie Thorn; Duncan Stewart; Rob Beanlands; Robert A deKemp; Jean N DaSilva; Lisa M Mielniczuk
Journal:  J Nucl Cardiol       Date:  2016-09-29       Impact factor: 5.952

Review 8.  State of the art: advanced imaging of the right ventricle and pulmonary circulation in humans (2013 Grover Conference series).

Authors:  Mariëlle C van de Veerdonk; J Tim Marcus; Harm-Jan Bogaard; Anton Vonk Noordegraaf
Journal:  Pulm Circ       Date:  2014-06       Impact factor: 3.017

9.  The role of nuclear imaging in pulmonary hypertension.

Authors:  H Ohira; R S Beanlands; R A Davies; L Mielniczuk
Journal:  J Nucl Cardiol       Date:  2014-08-27       Impact factor: 5.952

10.  Fasting 2-deoxy-2-[18F]fluoro-D-glucose positron emission tomography to detect metabolic changes in pulmonary arterial hypertension hearts over 1 year.

Authors:  Erika L Lundgrin; Margaret M Park; Jacqueline Sharp; W H Wilson Tang; James D Thomas; Kewal Asosingh; Suzy A Comhair; Frank P DiFilippo; Donald R Neumann; Laura Davis; Brian B Graham; Rubin M Tuder; Iva Dostanic; Serpil C Erzurum
Journal:  Ann Am Thorac Soc       Date:  2013-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.